Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab.
Lu G, Zhu P, Rao M, Linendoll N, Buja LM, Bhattacharjee MB, Brown RE, Ballester LY, Tian X, Pilichowska M, Wu JK, Hergenroeder GW, Glass WF, Chen L, Zhang R, Pillai AK, Hunter RL, Zhu JJ.
Lu G, et al. Among authors: linendoll n.
J Neurooncol. 2022 Oct;160(1):221-231. doi: 10.1007/s11060-022-04144-y. Epub 2022 Oct 6.
J Neurooncol. 2022.
PMID: 36203027